Trial · NCT03179631
Results by group176
Each measurement the trial posted, group by group, in the words and numbers it posted.
21 to 40 of 176
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| DB Period: Composite of Average Change From Baseline in TFTs at Week 72 - mITT Population | Ataluren | 4.15 | Standard Error 0.435 | seconds | |
| DB Period: Composite of Average Change From Baseline in TFTs at Week 72 - mITT Population | Placebo | 5.19 | Standard Error 0.431 | seconds | |
| DB Period: Composite of Average Change From Baseline in TFTs at Week 72 - ITT Population | Ataluren | 4.24 | Standard Error 0.309 | seconds | |
| DB Period: Composite of Average Change From Baseline in TFTs at Week 72 - ITT Population | Placebo | 4.93 | Standard Error 0.319 | seconds | |
| DB Period: Composite of Average Rate of Change From Baseline in TFTs at Week 72 - mITT Population | Ataluren | 0.058 | Standard Error 0.006 | seconds/week | |
| DB Period: Composite of Average Rate of Change From Baseline in TFTs at Week 72 - mITT Population | Placebo | 0.072 | Standard Error 0.006 | seconds/week | |
| DB Period: Composite of Average Rate of Change From Baseline in TFTs at Week 72 - ITT Population | Ataluren | 0.059 | Standard Error 0.004 | seconds/week | |
| DB Period: Composite of Average Rate of Change From Baseline in TFTs at Week 72 - ITT Population | Placebo | 0.069 | Standard Error 0.004 | seconds/week | |
| DB Period: Time to Persistent 10% Worsening in 6MWD at Week 72 - mITT Population | Ataluren | 36.7 | 95% Confidence Interval 36.0 | weeks | |
| DB Period: Time to Persistent 10% Worsening in 6MWD at Week 72 - mITT Population | Placebo | 35.6 | 95% Confidence Interval 23.7 | weeks | |
| DB Period: Time to Persistent 10% Worsening in 6MWD - ITT Population | Ataluren | 74.3 | 95% Confidence Interval 59.1 to NA | weeks | |
| DB Period: Time to Persistent 10% Worsening in 6MWD - ITT Population | Placebo | 48.0 | 95% Confidence Interval 36.0 to 60.9 | weeks | |
| DB Period: Change From Baseline in North Start Ambulatory Assessment (NSAA) Total Score at Week 72 - mITT Population | Ataluren | -5.2 | Standard Error 0.40 | units on a scale | |
| DB Period: Change From Baseline in North Start Ambulatory Assessment (NSAA) Total Score at Week 72 - mITT Population | Placebo | -6.1 | Standard Error 0.40 | units on a scale | |
| DB Period: Change From Baseline in NSAA Total Score at Week 72 - ITT Population | Ataluren | -3.7 | Standard Error 0.28 | units on a scale | |
| DB Period: Change From Baseline in NSAA Total Score at Week 72 - ITT Population | Placebo | -4.5 | Standard Error 0.29 | units on a scale | |
| DB Period: Time to Loss of Ambulation - mITT Population | Ataluren | 84.1 | 95% Confidence Interval 84.1 to NA | weeks | |
| DB Period: Time to Loss of Ambulation - mITT Population | Placebo | NA | 95% Confidence Interval NA to NA | weeks | |
| DB Period: Time to Loss of Ambulation Over 72 Weeks - ITT Population | Ataluren | NA | 95% Confidence Interval NA to NA | weeks | |
| DB Period: Time to Loss of Ambulation Over 72 Weeks - ITT Population | Placebo | NA | 95% Confidence Interval NA to NA | weeks |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03179631/results?page=2